Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
OrbiMed’s $125 Million Debt Financing
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Marathon Asset Management’s $100 Million Loan to Theratechnologies
Covington advised Marathon Asset Management LP on the deal. Marathon Asset Management LP announced a non-dilutive term loan for up to $100 million to Theratechnologies Inc. Marathon...